The mandatory CAM testing of cells and scaffolds for tissue engineering: Benefits for the three Rs of cooperation with the vaccine industry

ATLA Alternatives to Laboratory Animals

Volumn 32, Issue 6, 2004, Pages 573-580

  Falkner, Erwin ^a   Eder, Claudia ^a   Kapeller, Barbara ^a   Fröschl, Walter ^b   Schmatz, Christine ^b   Macfelda, Karin ^a   Losert, Udo M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b BAXTER INNOVATIONS GMBH   (Austria)

Author keywords

Angiogenesis; Biomaterial; Cell tissue implantation transplantation; Chorio allantoic membrane; HET CAM; Tissue engineering

Indexed keywords

VACCINE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TESTING REDUCTION; ANIMAL TESTING REFINEMENT; ANIMAL TESTING REPLACEMENT; ARTICLE; AUSTRIA; CELL CULTURE; CHICKEN; CHORIOALLANTOIS; DRUG INDUSTRY; EGG; HISTOLOGY; NONHUMAN; PRIORITY JOURNAL; TISSUE ENGINEERING;

EID: 14644435830     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290403200608     Document Type: Article

References (19)

1. Kalweit, S., Gerner, I. & Spielmann, H. (1988). Validation project of alternatives for the Draize eye test. Molecular Toxicology 1, 597-603.
2. Spielmann, H. (1995). HET-CAM test. Methods in Molecular Biology 43, 199-204.
3. Borges, J., Tegtmeier, F.T., Padron, N.T., Mueller, M.C., Lang, E.M. & Stark, G.B. (2003). Chorioallantoic membrane angiogenesis model for tissue engineering: a new twist on a classic model. Tissue Engineering 9, 441-450.
4. Vollrath, F., Barth, P., Basedow, A., Engstrom, W. & List, H. (2002). Local tolerance to spider silks and protein polymers in vivo. In Vivo 16, 229-234.
5. Jux, C., Wohlsein, P., Bruegmann, M., Zutz, M., Franzbach, B. & Bertram, H. (2003). A new biological matrix for septal occlusion. Journal of Interventional Cardiology 16, 149-152.
6. Kunzi-Rapp, K., Genze, F., Kufer, R., Reich, E., Hautmann, R.E. & Gschwend, J.E. (2001). Chorioallantoic membrane assay: vascularized 3-dimensional cell culture system for human prostate cancer cells as an animal substitute model. Journal of Urology 166, 1502-1507.
7. Hamburger, V. & Hamilton, H. L. (1992). A series of normal stages in the development of the chick embryo. Developmental Dynamics 195, 231-272
8. Lee, C.R., Grodzinsky, A.J., Hsu, H.P. & Spector, M. (2003). Effects of a cultured autologous chondrocyte-seeded type II collagen scaffold on the healing of a chondral defect in a canine model. Journal of Orthopaedic Research 21, 272-281.
9. Sicard, R.E. & Nguyen, L.M. (1996). An in vivo model for evaluating wound repair and regeneration microenvironments. In Vivo 10, 477-481.
10. Hartung, T., Balls, M., Bardouille, C., Blanck, O., Coecke, S., Gstraunthaler, G. & Lewis, D. (2002). Good cell culture practice. ATLA 30, 407-414.
11. Falkner, E., Schöffl, H., Appl, H., Losert, U.M., Pfaller, W. & Macfelda, K. (2003). Replacement of Sera for Cell Culture Purposes: A Survey, 175 pp. Linz, Austria: ZET. Web site http://www.zet.or (Accessed 12.1.05).
12. Auerbach, R., Kubai, L., Knighton, D. & Folkman, J. (1974). A simple procedure for the long-term cultivation of chick embryos. Developmental Biology 41, 391-394.
13. Ribatti, D., Gualandris, A., Bastaki, M., Vacca, A., Roncali, L. & Presta, M. (1997). A new model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane (CAM): the gelatin sponge/CAM assay. Journal of Vascular Research 34, 455-463.
14. Ribatti, D., Gualandris, A., Belleri, M., Massardi, L., Nico, B., Rusnati, M., Dell'Era, P., Vacca, A., Roncali, L. & Presta, M. (1999). Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2. Journal of Pathology 189, 590-599.
15. Pacini, S., Gulisano, M., Vannucchi, S. & Ruggiero, M. (2002). Poly-L-lysine/heparin stimulates angiogenesis in chick embryo chorioallantoic membrane. Biochemical and Biophysical Research Communications 290, 820-823.
16. Holzmann, P. (2002). The Chorioallantoic Membrane (CAM) of the Chick Embryo, 180pp. [Original in German: Die Chorioallantoismembran des Huehner-embryos.] Dissertation. Vienna, Austria: University of Vienna.
17. Schuttle, E., Picciolo, G. & Kaplan, D. (2004). Tissue Engineered Medical Products Standards, 280pp. West Conshohocken, PA, USA: ASTM International. Web site http://www.ASTM.org (Accessed 12.1.05).
18. ASTM International. (2003). F748-98 Standard Practice for Selecting Generic Biological Test Methods for Materials and Devices, 7pp. West Conshohocken, PA, USA: ASTM International. Web site http://www.ASTM.org (Accessed 12.1.05).
19. Falkner, E., Frick, W., Kapeller, B., Eberl, H., Macfelda, K. & Losert, U.M. (2000). Concerning cell cultures for biocompatibility-testing: monitoring by DNA-fingerprinting. ALTEX 17, 135-137.